SCHEMBL8580389

SCHEMBL8580389

CC(Nc1ncnc2[nH]nc(NCc3ccccc3)c12)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 7/20 0.55
CDK1 P06493 4/20 0.55
ABL1 P00519 1/20 0.55
PRKCA P17252 1/20 0.55
CCNB2 O95067 1/20 0.50
CCNB1 P14635 1/20 0.50
CCNB3 Q8WWL7 1/20 0.50
LMNA P02545 2/20 0.48
SRC P12931 1/20 0.47
GALR3 O60755 1/20 0.47
NR2F2 P24468 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CSF1R P07333 1/20 0.45
HTR7 P34969 1/20 0.44
KDR P35968 2/20 0.44
HDAC3 O15379 1/20 0.44
ERBB2 P04626 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8580393 1.00 EGFR (0.55) EGFRCDK1ABL1PRKCACCNB2
SCHEMBL8578059 0.93 EGFR (0.51) EGFRCDK1ABL1PRKCACCNB2
SCHEMBL8581912 0.93 EGFR (0.51) EGFRCDK1ABL1PRKCACCNB2
SCHEMBL8578063 0.93 EGFR (0.51) EGFRCDK1ABL1PRKCACCNB2
SCHEMBL8581825 0.88 EGFR (0.49) EGFRCDK1ABL1PRKCASRC
SCHEMBL8579768 0.88 EGFR (0.49) EGFRCDK1ABL1PRKCASRC
SCHEMBL8579766 0.88 EGFR (0.47) EGFRCDK1ABL1PRKCASMN1; SMN2
SCHEMBL8651281 0.88 EGFR (0.47) EGFRCDK1ABL1PRKCASMN1; SMN2
SCHEMBL8579778 0.88 EGFR (0.47) EGFRCDK1ABL1PRKCASMN1; SMN2
SCHEMBL8577216 0.86 EGFR (0.52) EGFRCDK1ABL1PRKCACCNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998014449-A1 FUSED PYRAZOLE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 1998-04-09 WO claimed